Robert Bain Thomas, Director at REVA Medical, Inc. (RVA), bought 25,000 shares at $3.85 ($39K) on 2015-05-28, disclosed to the SEC on 2015-05-29.
Open-market purchase of $38k RVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,000 | $0 | 0.0% |
| 2 | $3.85 | 10,000 | $39K | 100.0% |
| Total | $1.54 avg | 25,000 | $39K | 100% |
| Filing → |
| RVA.AX | BUY | 2018-06-01 | $10K | — | Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |